U.S. Securities & Exchange Commission Pixel
SEC Seal
US Flag background Home | FAQ Pixel
Pixel
U.S. Securities and Exchange Commission Pixel
Pixel
US Flag background Pixel Pixel
Pixel Banner Seal Bottom Front

Full-Text Search

This page allows you to search the full text of EDGAR filings from the last four years. The full text of a filing includes all data in the filing as well as all attachments to the filing. To find the information you need and make your search easy and enjoyable, please visit our FAQ page. We are still developing this feature, and we plan to enhance it based on user feedback. Please email your comments and suggestions for improvement to textsearch@sec.gov.

Note: Occasionally, some recent filings are not available through the EDGAR Full-Text Search.


Pixel Pixel
: Basic Search Page
: :
:
:
:
:
 Click here for Calendar  Click here for Calendar

Date Filed Title
03/25/2019PRE 14A for CTI BIOPHARMA CORP    
 COMPANY NAME(s) - [CTI BIOPHARMA CORP (CIK - 891293 /SIC - 2834)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant: Filed by a Party other than the Registrant: Check the appropriate box: Preliminary Proxy
 
03/25/2019PX14A6G for Allergan plc    
 COMPANY NAME(s) - [Allergan plc (CIK - 1578845 /SIC - 2834), Appaloosa LP (CIK - 1656456 /SIC - )]
 U.S. Securities and Exchange Commission Washington, DC 20549 Notice of Exempt Solicitation Amendment No. 4 NAME OF REGISTRANT: Allergan plc NAME OF PERSON RELYING ON EXEMPTION: Appaloosa LP ADDRESS OF PERSON RELYING ON EXEMPTION: 51 John F. Kennedy Parkway, Short Hills, New Jersey 07078 WRITTEN
 
03/25/201910-K for DarioHealth Corp    
 COMPANY NAME(s) - [DarioHealth Corp (CIK - 1533998 /SIC - 3841)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF
 
03/25/20194 for STAGE STORES INC    
 COMPANY NAME(s) - [STAGE STORES INC (CIK - 6885 /SIC - 5651), HUNTER STEVEN L (CIK - 1486546 /SIC - )]
 X0306 4 2019-03-24 0 0000006885 STAGE STORES INC SSI 0001486546 HUNTER STEVEN L 2425 WEST LOOP SOUTH HOUSTON TX 77027 0 1 0 0 EVP, COO - Gordmans Common Stock 2019-03-24 4 F 0 2273 1 D 99994 D /s/ R.E. Stasyszen, Attorney in Fact for Steven L. Hunter 2019-03-25
 
03/25/2019DEF 14A for KRONOS WORLDWIDE INC    
 COMPANY NAME(s) - [KRONOS WORLDWIDE INC (CIK - 1257640 /SIC - 2810)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant: Filed by a Party other than the
 
03/25/20198-K for HORMEL FOODS CORP DE    
 COMPANY NAME(s) - [HORMEL FOODS CORP DE (CIK - 48465 /SIC - 2011)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 25, 2019 HORMEL FOODS CORPORATION (Exact name of
 
03/25/20194 for LOWES COMPANIES INC    
 COMPANY NAME(s) - [LOWES COMPANIES INC (CIK - 60667 /SIC - 5211), Weber Jennifer L (CIK - 1336656 /SIC - )]
 By: /s/ Sandra Felton by power of attorney for: Jennifer L. Weber 2019-03-25
 
03/25/20198-K for WINNEBAGO INDUSTRIES INC    
 COMPANY NAME(s) - [WINNEBAGO INDUSTRIES INC (CIK - 107687 /SIC - 3716)]
 Date: March 25, 2019 By: /s/ Bryan L. Hughes Name: Bryan L. Hughes Title: Vice President, Chief Financial Officer
 
03/25/201910-K for PROTECTIVE LIFE INSURANCE CO    
 COMPANY NAME(s) - [PROTECTIVE LIFE INSURANCE CO (CIK - 310826 /SIC - 6311)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 _ FORM 10-K x Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended December 31, 2018 or Transition Report Pursuant to Section 13 or 15(d) of the Securities
 
03/25/20198-K for BBX Capital Corp    
 COMPANY NAME(s) - [BBX Capital Corp (CIK - 315858 /SIC - 6500)]
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 25, 2019 BBX CAPITAL CORPORATION (Exact name of